| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 4e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |